Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.01 Billion USD | -29.79% |
| 2022 | 17.12 Billion USD | 2.21% |
| 2021 | 16.75 Billion USD | 1.58% |
| 2020 | 16.48 Billion USD | 27.43% |
| 2019 | 12.94 Billion USD | 38.49% |
| 2018 | 9.34 Billion USD | 11.48% |
| 2017 | 8.38 Billion USD | 26.9% |
| 2016 | 6.6 Billion USD | 9.32% |
| 2015 | 6.04 Billion USD | 4.28% |
| 2014 | 5.79 Billion USD | 4.12% |
| 2013 | 5.56 Billion USD | 12.87% |
| 2012 | 4.92 Billion USD | 14.14% |
| 2011 | 4.31 Billion USD | 7.84% |
| 2010 | 4 Billion USD | 15.39% |
| 2009 | 3.47 Billion USD | 23.71% |
| 2008 | 2.8 Billion USD | 24.68% |
| 2007 | 2.25 Billion USD | 69.06% |
| 2006 | 1.33 Billion USD | 82.79% |
| 2005 | 728.19 Million USD | 9.26% |
| 2004 | 666.46 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 12.67 Billion USD | -3.79% |
| 2023 Q1 | 16.53 Billion EUR | 3.36% |
| 2023 FY | 12.01 Billion EUR | -24.86% |
| 2023 Q3 | 12.01 Billion EUR | -27.31% |
| 2023 Q2 | 18.03 Billion USD | 5.34% |
| 2023 Q4 | 13.26 Billion USD | -26.44% |
| 2022 Q2 | 16.85 Billion USD | -2.3% |
| 2022 FY | 15.99 Billion EUR | 5.43% |
| 2022 Q4 | 17.12 Billion USD | 1.6% |
| 2022 Q1 | 16.07 Billion EUR | 5.97% |
| 2022 Q3 | 15.99 Billion EUR | -0.51% |
| 2021 Q2 | 16.81 Billion USD | 1.99% |
| 2021 Q4 | 17.24 Billion USD | 2.55% |
| 2021 Q3 | 14.73 Billion EUR | 3.91% |
| 2021 FY | 15.17 Billion EUR | 12.59% |
| 2021 Q1 | 14.18 Billion EUR | 5.23% |
| 2020 Q4 | 16.48 Billion USD | 17.89% |
| 2020 FY | 13.47 Billion EUR | 16.9% |
| 2020 Q1 | 12.45 Billion EUR | 8.03% |
| 2020 Q2 | 13.98 Billion USD | 8.09% |
| 2020 Q3 | 13.47 Billion EUR | 8.22% |
| 2019 Q1 | 11.4 Billion EUR | 39.58% |
| 2019 Q2 | 12.99 Billion USD | 39.05% |
| 2019 FY | 11.52 Billion EUR | 41.03% |
| 2019 Q3 | 11.52 Billion EUR | 1.04% |
| 2019 Q4 | 12.94 Billion USD | -0.4% |
| 2018 Q2 | 8.97 Billion USD | 7.05% |
| 2018 Q3 | 8.17 Billion EUR | 6.36% |
| 2018 Q1 | 7.68 Billion EUR | 10.1% |
| 2018 FY | 8.17 Billion EUR | 17.1% |
| 2018 Q4 | 9.34 Billion USD | 4.13% |
| 2017 Q4 | 8.38 Billion USD | 3.12% |
| 2017 Q1 | 7.12 Billion EUR | 14.04% |
| 2017 FY | 6.98 Billion EUR | 11.69% |
| 2017 Q2 | 8.12 Billion USD | 23.31% |
| 2017 Q3 | 6.98 Billion EUR | -2.06% |
| 2016 Q3 | 6.26 Billion EUR | 4.19% |
| 2016 Q4 | 6.59 Billion USD | 9.68% |
| 2016 Q2 | 6 Billion EUR | 0.0% |
| 2016 FY | 6.24 Billion EUR | 12.37% |
| 2016 Q1 | 6 Billion EUR | 8.06% |
| 2015 Q1 | 5.01 Billion EUR | 4.69% |
| 2015 Q2 | 5.01 Billion EUR | 0.0% |
| 2015 Q3 | 5.56 Billion EUR | 10.96% |
| 2015 FY | 5.56 Billion EUR | 16.16% |
| 2015 Q4 | 5.56 Billion EUR | 0.0% |
| 2014 Q1 | 4.44 Billion EUR | 10.05% |
| 2014 FY | 4.78 Billion EUR | 18.56% |
| 2014 Q4 | 4.78 Billion EUR | 0.0% |
| 2014 Q3 | 4.78 Billion EUR | 7.74% |
| 2014 Q2 | 4.44 Billion EUR | 0.0% |
| 2013 Q1 | 3.8 Billion EUR | 1.8% |
| 2013 Q3 | 4.03 Billion EUR | 6.09% |
| 2013 Q4 | 4.03 Billion EUR | 0.0% |
| 2013 FY | 4.03 Billion EUR | 8.0% |
| 2013 Q2 | 3.8 Billion EUR | 0.0% |
| 2012 Q4 | 3.73 Billion EUR | 0.0% |
| 2012 FY | 3.73 Billion EUR | 12.38% |
| 2012 Q2 | 3.4 Billion EUR | 0.0% |
| 2011 FY | 3.32 Billion EUR | 11.45% |
| 2011 Q4 | 3.32 Billion EUR | 0.0% |
| 2011 Q2 | 3.07 Billion EUR | 0.0% |
| 2010 Q4 | 2.98 Billion EUR | 0.0% |
| 2010 FY | 2.98 Billion EUR | 23.4% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 Q2 | 2.14 Billion EUR | 0.0% |
| 2009 FY | 2.41 Billion EUR | 19.12% |
| 2009 Q4 | 2.41 Billion EUR | 0.0% |
| 2008 FY | 2.03 Billion EUR | 31.95% |
| 2007 FY | 1.53 Billion EUR | 69.85% |
| 2006 FY | 906.2 Million EUR | 46.36% |
| 2005 FY | 619.14 Million EUR | 26.27% |
| 2004 FY | 490.31 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -48543.24% |
| Arem Pacific Corporation | 304.9 Thousand USD | -3941996.995% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -6526352.622% |
| BioCorRx Inc. | 10.34 Million USD | -116127.582% |
| Bionik Laboratories Corp. | 5 Million USD | -240160.978% |
| Banyan Corp. | 4.51 Million USD | -265911.897% |
| Clearday, Inc. | 65.13 Million USD | -18354.147% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -666875.491% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -799162943.045% |
| Empower Clinics Inc. | 9.18 Million USD | -130750.34% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -37872.591% |
| Selectis Health, Inc. | 43.63 Million USD | -27445.555% |
| Ethema Health Corporation | 17.71 Million USD | -67732.624% |
| HealthLynked Corp. | 3.47 Million USD | -345746.159% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -82938.195% |
| JRSIS Health Care Corporation | 2.3 Million USD | -521316.447% |
| Comjoyful International Company | 6.32 Million USD | -189899.866% |
| Medical Facilities Corporation | 235.37 Million USD | -5006.637% |
| MedSmart Group Inc. | 927.53 Thousand USD | -1295767.416% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -1282877.211% |
| Nova Leap Health Corp. | 2.69 Million USD | -445241.532% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -416937.382% |
| PAO Group, Inc. | 1.04 Million USD | -1148381.6% |
| Primemd Inc. | 7.98 Million USD | -150357.303% |
| Raffles Medical Group Ltd | 367.04 Million USD | -3174.663% |
| Ryman Healthcare Limited | 5.17 Billion USD | -132.04% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -14926409.78% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -306849.121% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -282865.062% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -1777943.195% |
| Veltex Corporation | 2.87 Million USD | -417646.881% |
| World Financial Holding Group | 132.5 Thousand USD | -9070932.791% |
| Xcelerate Inc. | 2.07 Million USD | -578997.405% |